Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2113521 | Cancer Letters | 2011 | 8 Pages |
Previously, we reported that a novel secretory protein, pancreatic adenocarcinoma up-regulated factor (PAUF), which is highly expressed in pancreatic cancer and mediates the growth and metastasis of pancreatic cancer cells. In this study, we generated and characterized a 2′-fluoropyrimidine modified RNA aptamer (P12FR2) directed against human PAUF. P12FR2 binds specifically to human PAUF with an estimated apparent KD of 77 nM. P12FR2 aptamer inhibits PAUF-induced migration of PANC-1, human pancreatic cancer cells, in a wound healing assay. Moreover, intraperitoneal injection of P12FR2 decreased tumor growth by about 60% in an in vivo xenograft model with CFPAC-1 pancreatic cancer cells, without causing a loss of weight in the treated mice. Taken together, we propose here that PAUF-specific RNA aptamer, P12FR2, has the potential to be effective in the therapy of human pancreatic cancer.
► We generated and characterized a 2′-fluoropyrimidine modified RNA aptamer directed against human PAUF. ► The PAUF aptamer inhibits PAUF-induced migration of PANC-1, human pancreatic cancer cells. ► The PAUF aptamer decreased tumor growth in an in vivo xenograft model. ► The PAUF-specific RNA aptamer has the potential to be effective in the therapy of human pancreatic cancer.